Scarica l'app Stockscreener
14.53
3.64%
0.51
Dopo l'orario di chiusura:
14.53
Omada Health Inc Borsa (OMDA) Ultime notizie
Could This $14 Stock Be Your Ticket to Millionaire Status? - Yahoo Finance
[144] Omada Health, Inc. SEC Filing - Stock Titan
Earnings call transcript: Omada Health Q4 2025 reports surprising earnings beat - Investing.com Nigeria
OMDA Should I Buy - Intellectia AI
Prescribed Health Apps Market Set to Witness Rapid Growth - openPR.com
Sean Duffy Sells 4,063 Shares of Omada Health (NASDAQ:OMDA) Stock - MarketBeat
Omada Health Earnings Call Highlights Profitable Growth - TipRanks
Digital Medicine Market Is Going to Boom Rapidly | Pear Therapeutics Inc., Omada Health Inc., Propeller Health - openPR.com
Digiceuticals Market Set to Witness Rapid Growth Through 2033 | - openPR.com
Best IPO Stocks to Buy in 2026: Latest Upcoming Stocks to Watch - The Motley Fool
Omada Health (OMDA) CEO logs tax-withholding share disposal on Form 4 - Stock Titan
Sean Duffy sells OMDA stock (NASDAQ: OMDA) in 10b5-1 trades - Stock Titan
OMDA Stock Price and Chart — NASDAQ:OMDA - TradingView
Omada Health: GLP-1-Focused Telehealth Platform Users May Feel They Can Do Without (OMDA) - Seeking Alpha
Health Coach Market Outlook 2026-2033: Growth Drivers, Trends, - openPR.com
Why Omada Health (OMDA) Is Up 14.4% After First GAAP Profit And GLP-1 Flex Launch - Yahoo Finance
Omada Health (OMDA) Is Up 14.4% After GLP-1 Flex Launch and Narrowed 2025 Net Loss - Sahm
BMO cuts Omada Health stock price target on valuation pressure - Investing.com Australia
Omada Health (NASDAQ:OMDA) Q4 2025 earnings call transcript - MSN
Compared to estimates, Omada Health, Inc. (OMDA) Q4 earnings: A look at key metrics - MSN
Omada Health (OMDA) Turns Q4 EPS Profit As Bulls’ Growth Narrative Faces Trailing Losses - simplywall.st
Omada Health 10-K: Revenue $260.2M, EPS $(0.35) - TradingView
Omada Health reports Q4 profit, offers new GLP-1 cash-pay option - TechTarget
Omada Health (NASDAQ:OMDA) Price Target Cut to $18.00 by Analysts at BMO Capital Markets - MarketBeat
Omada Health, Inc. Experiences Revision in Its Stock Evaluation Amid Mixed Market Signals - Markets Mojo
Morgan Stanley Maintains Overweight Rating on OMDA | OMDA Stock News - GuruFocus
Omada Health: Profitability Inflection, Double-Digit Growth Outlook, and Undervalued Upside Support Buy Rating - TipRanks
Omada Health (NASDAQ:OMDA) Given New $30.00 Price Target at Morgan Stanley - MarketBeat
Barclays Raises Price Target for Omada Health (OMDA) to $18.00 | - GuruFocus
Evercore ISI cuts Omada Health stock price target on valuation - Investing.com India
BMO cuts Omada Health stock price target on valuation pressure By Investing.com - Investing.com India
Evercore ISI cuts Omada Health stock price target on valuation By Investing.com - Investing.com South Africa
Why Is Omada Health Stock Soaring Friday?Omada Health (NASDAQ:OMDA) - Benzinga
Omada Health Q4 2025 Earnings Call Summary - Yahoo Finance
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Omada Health Stock Pre-Market (+10%): Q4 Beat, Surprise Profit & Strong 2026 Guidance - Trefis
Omada Health launches GLP-1 program for cost-conscious employers By Investing.com - Investing.com Canada
Omada Health (OMDA) Q4 2025 Earnings Transcript - The Globe and Mail
Omada Health Q4 Earnings Call Highlights - Yahoo Finance
Omada Health Q4 2025 Earnings Call Transcript - MarketBeat
Compared to Estimates, Omada Health, Inc. (OMDA) Q4 Earnings: A Look at Key Metrics - Bitget
Omada Health Q4 Swings to Earnings, Revenue Rises; 2026 Revenue Outlook Issued - marketscreener.com
Hims & Hers Stumbles at the Open as Regulatory Damage Hits 2026 Outlook Hard - AOL.com
Earnings Flash (OMDA) Omada Health Posts Q4 EPS $0.08, vs. FactSet Est of $0.01 - marketscreener.com
Omada Health Announces GLP-1 Flex Care, Giving Employers a New, Flexible Path to Support Obesity Care - The Manila Times
Omada Health Reports Fourth Quarter and Full-Year 2025 Results - The Manila Times
Earnings Flash (OMDA) Omada Health, Inc. Reports Q4 Revenue $75.8M, vs. FactSet Est of $70.2M - marketscreener.com
Assessing Omada Health: Insights From 4 Financial Analysts - Benzinga
Barclays Lowers Price Target for OMDA, Maintains Overweight Rati - GuruFocus
Omada Health (NASDAQ:OMDA) Given New $17.00 Price Target at Barclays - MarketBeat
Digital Therapeutics Market to Reach US$ 39.52 Billion by 2033 | - openPR.com
7MM Digital Therapeutics for Diabetes Market Set for Strong - openPR.com
BIT Capital GmbH Makes New $13.64 Million Investment in Omada Health, Inc. $OMDA - MarketBeat
0.79%
1.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):